The evidence base for plant-based ketogenic diets as a distinct category is less developed than for either plant-based eating or ketogenic diets in isolation. However, the mechanistic rationale for expecting additive benefits is strong, and the emerging evidence from hybrid dietary pattern studies is consistent with this expectation. The Eco-Atkins trials from David Jenkins' group at the University of Toronto remain the most rigorous human evidence for a low-carbohydrate plant-predominant dietary pattern.
Cardiovascular Risk Markers
The Eco-Atkins trial found that a plant-based low-carbohydrate diet reduced LDL cholesterol by approximately 8.5 per cent more than a high-carbohydrate lacto-vegetarian control, reduced blood pressure significantly more, and produced greater reductions in LDL to HDL ratio. Conventional animal-fat ketogenic diets, by contrast, frequently raise LDL cholesterol, particularly LDL particle count and small dense LDL, due to their high saturated fat content. Plant-based keto achieves the glycaemic and metabolic benefits of ketosis while maintaining the LDL-lowering properties of plant-derived fats and plant sterols.
Metabolic and Weight Effects
Ketogenic diets across multiple randomised trials produce greater short-term weight loss than isocaloric low-fat diets, primarily through the appetite-suppressing effects of ketosis, glycogen-bound water loss, and reduced insulin-driven fat storage. Plant-based diets independently produce beneficial metabolic effects through their high fibre content, lower energy density, and specific effects of plant-based protein on appetite-regulating hormones. Combining these two mechanisms may produce more sustained weight loss and metabolic improvement than either approach independently, though long-term randomised trial data specifically for plant-based keto remains limited.
Inflammatory Markers
Both ketosis and plant-predominant eating independently reduce inflammatory markers. Beta-hydroxybutyrate inhibits the NLRP3 inflammasome, one of the primary triggers of sterile inflammation. Plant polyphenols inhibit NF-kB. Omega-3 fatty acids from nuts and seeds, combined with algae-based DHA supplementation, shift the pro-inflammatory omega-6 dominance of standard Western diets. The combination produces anti-inflammatory effects through multiple non-overlapping mechanisms, potentially explaining the superior inflammatory marker reductions seen in the Eco-Atkins studies compared to either standard keto or standard plant-based comparators.
Gut Microbiome Considerations
A criticism of conventional ketogenic diets is that their low fibre content reduces gut microbiome diversity over time. Animal-fat-based keto reduces the fermentable substrate available to beneficial microbiota, potentially reducing short-chain fatty acid production and compromising the anti-inflammatory gut-brain axis benefits associated with diverse microbiome. Plant-based keto, by emphasising non-starchy vegetables, nuts, seeds, and limited legumes, maintains higher fibre intake than conventional keto, partially addressing this concern while still maintaining adequate ketosis through carbohydrate restriction from starchy and sugary sources.